PPAR gamma agonists for treatment of multiple sclerosis
AssigneeInteKrin Therapeutics, Inc.
InventorDavid Weinstein
Life of this patent
Estimating the term…
Abstract
Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:
Claims6
A method of treating relapsing and remitting multiple sclerosis (RRMS) in a patient in need thereof at a regular dosing interval comprising administering to said patient a pharmaceutical composition comprising from about 1 to about 3 milligrams of a compound of formula (I),
- or a pharmaceutically acceptable salt, prodrug, or isomer thereof.
A method of treating the symptoms of relapsing and remitting multiple sclerosis (RRMS) comprising administering to a patient in need thereof at a regular dosing interval from about 1 to about 3 milligrams of a compound of formula (I),
- or a pharmaceutically acceptable salt, prodrug or isomer thereof.
Dependencies are inferred from the claim text.